Marpai, Inc.
Close on Oct 19, 2026
- Market cap
- $82.24M
- P/E (TTM)
- –
- Dividend yield
- –
About Marpai
Services-Misc Health & Allied Services, NEC, SIC 8090
Marpai, Inc. is a healthcare technology platform company operating subsidiaries that provide third-party administrator and pharmacy benefit management services. The business serves self-insured employers who directly fund employee healthcare programs, with a client base primarily comprising small and medium-sized enterprises as well as local government entities. Its activities span three main revenue streams: health plan administration, in-house ancillary offerings, and third-party vendor services. These solutions include custom benefit plan design, claims adjudication, clinical care navigation, out-of-network claims repricing, specialty drug savings, and comprehensive pharmacy benefit management.
The company focuses its operations on the self-funded healthcare sector across the United States and maintains an Israeli operating subsidiary known as EYME Technologies, Ltd. As of December 31, 2025, Marpai engaged a workforce of 107 full-time employees. The company maintains its principal executive offices and headquarters in Tampa, Florida.
Summary of the business section of Marpai's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Marpai, Inc.
- Headquarters
- Tampa, FL
- Address
- 615 Channelside Drive, Suite 207 33602
- Phone
- (646) 303-3483
- Employees
- 107, Dec 31, 2025
- Industry
- Services-Misc Health & Allied Services, NEC
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- UHY LLP, Melville, New York
Stock & identifiers
- Ticker
- MRAI
- Exchange
- OTC
- IPO date
- Oct 28, 2021
- Shares outstanding
- 27M, Aug 13, 2026
- Public float
- $9.75M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Stock splits
- 1-for-4 reverse, Jun 29, 2023; 1-for-4 reverse, Jun 29, 2023
- SEC CIK
- 1844392
- CUSIP
- 571354109
- ISIN
- US5713541093
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Damien Lamendola | Chief Executive Officer, Director | 2,581,674 |
| Steve Andrew Johnson | Chief Financial Officer | 1,024,192 |
| Dallas Scrip | Chief Operating Officer | 400,000 |
| John Paul Powers | President | 410,000 |
| Colleen DiClaudio | Director | 267,500 |
| Sagiv Shiv | Director | 613,667 |
| Robert M. Pons | Director | 484,200 |
| Jennifer Rosario Calabrese | Director | 225,000 |
| Yaron Eitan | Director | 1,224,073 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2024 | $362.00K | $712.00K | $514.00K | $25 | – |
| FY2023 | $292.00K | $288.00K | $2.29M | $53 | – |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“we had a total of 107 full-time employees.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Jun 3, 2024 | Delisting | Notice of delisting from exchange (Form 25) |
| May 24, 2024 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Nov 29, 2023 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Oct 6, 2023 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Jun 2, 2023 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Jan 13, 2023 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Jan 10, 2023 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Nov 1, 2022 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Dec 9, 2021 | Late filing | Notification of late filing |
| Oct 28, 2021 | IPO | Initial public offering priced (424B4 prospectus) |
| Oct 13, 2021 | Listing | Registration of securities on an exchange (Form 8-A) |